The p53 tumor suppressor is a nucleocytoplasmic shuttling protein that is found predominantly in the nucleus of cells. In addition to mutation, abnormal p53 cellular localization is one of the mechanisms that inactivate p53 function. To further understand features of p53 that contribute to the regulation of its trafficking within the cell, we analysed the subnuclear localization of wild-type and mutant p53 in human cells that were either permeabilized with detergent or treated with the proteasome inhibitor MG132. We, here, show that either endogenously expressed or exogenously added p53 protein localizes to the nucleolus in detergent-permeabilized cells in a concentration-and ATP hydrolysis-dependent manner. Two discrete regions within the carboxyl terminus of p53 are essential for nucleolar localization in permeabilized cells. Similarly, localization of p53 to the nucleolus after proteasome inhibition in unpermeabilized cells requires sequences within the carboxyl terminus of p53. Interestingly, genotoxic stress markedly decreases the association of p53 with the nucleolus, and phosphorylation of p53 at S392, a site that is modified by such stress, partially impairs its nucleolar localization. The possible significance of these findings is discussed.
Introduction
The human p53 protein contains 393 amino acids and is comprised of several functional domains (Prives and Hall, 1999) . Appropriate subcellular localization is crucial for regulating p53 function. Under unstressed conditions, the p53 protein is generally present at a low concentration, is presumably inactive as a transcription factor and is diffusely distributed throughout the cell. In response to DNA damage or other forms of cellular stress, p53 protein accumulates, frequently becomes extensively post-translationally modified and concentrates within the nucleus (Giaccia and Kastan, 1998; Appella and Anderson, 2001; Liang and Clarke, 2001; Prives and Manley, 2001) .
One property of the nucleus, analogous to cytoplasmic organelles, is the existence of subnuclear domains. These nuclear compartments concentrate specific sets of functionally related proteins. Within the nucleus, the nucleolus is the site of ribosomal RNA (rRNA) transcription, modification, maturation and ribosomal assembly (Carmo-Fonseca et al., 2000; Olson et al., 2000; . Although easily visualized as a discrete subnuclear entity, the nucleolus is not separated from the surrounding nucleoplasm by membranes, and thus proteins localize to nucleoli by processes that do not involve active membrane transport. In recent years, multiple proteins involved in cell-cycle progression were identified, whose regulation involves sequestration within the nucleolus. In response to oncogenic stress, the p14 ARF protein may inactivate the mouse double minute (MDM)2 oncoprotein (an inhibitor of p53) by inducing nucleolar sequestration of MDM2 (Zhang et al., 1998; Tao and Levine, 1999; Weber et al., 1999; Ashcroft et al., 2000) . The requirement of MDM2 localization to nucleoli for its inactivation by p14 ARF , however, is not obligatory (Llanos et al., 2001) . Among other cell cycle regulators and checkpoint factors that associate with the nucleolus are the Werner's Syndrome Helicase (Marciniak et al., 1998) , the telomere maintenance enzyme (hTERT) (Wong et al., 2002) and Cdc14, a protein phosphatase in yeast crucial for promoting exit from mitosis Visintin et al., 1998) . These and other findings imply a novel role for the nucleolus's participation in the regulation of cell cycle proteins (as reviewed in Visintin and Amon, 2000; Lamond and Sleeman, 2003; Mayer and Grummt, 2005; Olson and Dundr, 2005) .
Within the nucleus, p53 has been reported to be associated with at least three subnuclear compartments including the nucleolus, promyelocytic leukemia bodies and cajal bodies (Mogaki et al., 1993; Benninghoff et al., 1999; Rubbi and Milner, 2000; Horky et al., 2001; Klibanov et al., 2001; Wesierska-Gadek et al., 2002; Young et al., 2002; Zimber et al., 2004) . Approximately half of nuclear p53 is soluble, whereas the remainder associates with nuclear structures (Zerrahn et al., 1992) . p53 can interact with a number of nucleolar components such as L5 ribosomal protein (Marechal et al., 1994) , topoisomerase I (Gobert et al., 1996) , nucleolin (Daniely et al., 2002) , nucleophosmin (Colombo et al., 2002) and nucleostemin (Tsai and McKay, 2002) . Intriguingly as well, the first cellular DNA-binding site of p53 to be identified (RGC) is located within the ribosomal gene cluster (Kern et al., 1991) . Recently, it was reported that mutant p53 localizes to nucleoli in cells treated with a compound (PRIMA-1) that was reported to reactivate mutant forms of p53 (Bykov et al., 2002a, b; Rokaeus et al., 2006) .
Under non-stressed conditions, p53 was reported to localize to the nucleolus in permeabilized Hep G2 cells (Rubbi and Milner, 2000) . The nuclear and nucleolar association of p53 in such cells is RNA-dependent as RNase A treatment of permeabilized cells abrogates detection of most of the anchored p53. In addition, treatment of human fibroblasts with MG132, a proteasome inhibitor, causes p53 to accumulate in the nucleolus and nucleoplasm both in directly fixed cells and in permeabilized cells (Klibanov et al., 2001; Pokrovskaja et al., 2001; Latonen et al., 2003) . Although its functional significance is unknown, the nucleolar sequestration of p53 was reported to be one of the mechanisms contributing to the reactivation of p53 in HeLa cells after treatment with cisplatin (Horky et al., 2001; Wesierska-Gadek et al., 2002) .
In the present study, we have established conditions for characterizing the association of endogenously expressed or exogenously added p53 with nucleoli and have identified some of the requirements for this process.
RESULTS
The level of p53 within permeabilized H1299 cells determines nucleolar sequestration To investigate the localization of soluble and anchored p53 proteins within the nucleus, we used H1299 cells expressing tetracycline-regulated wild-type p53, transcriptionally impaired p53 Q22/S23 and a tumor-derived mutant p53 H175 ( Figure 1a ). Forty-eight hours after removal of tetracycline, cells were either immediately lysed in electrophoresis sample buffer (unpermeabilized, U) or first pre-permeabilized (P) in phosphate-buffered saline (PBS)/1% Triton X-100 for 2 min before lysis to remove soluble proteins. The cells were then subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting. Although levels of cellular proteins including p53 were reduced after permeabilization in the three clones, the remaining p53 protein was still readily detected ( Figure 1a ). The loss of p53 upon permeabilization may reflect the release of a subpopulation of p53 that is not bound to nuclear structures.
Parallel cultures to those in Figure 1a were either directly fixed with 4% paraformaldehyde (unpermeabilized) or first permeabilized with PBS/1% Triton X-100 for 2 min before fixation. Cells were then incubated with anti-p53 antibodies followed by incubation with secondary antibodies and analysis by laser scanning microscopy and differential interference contrast (DIC). As expected, without permeabilization wild-type and mutant p53 proteins were detected in the nucleoplasm of unpermeabilized cells and appeared to be excluded from nucleoli ( Figure 1b) . Interestingly, after permeabilization, nucleoplasmic staining was generally weaker in wild-type p53 cells, whereas in approximately 10-15% of cells expressing p53 Q22/S23 and p53 H175 almost exclusive nucleolar staining was observed ( Figure 1c ). By contrast, wild-type p53 was never observed in the nucleoli. Co-staining cells with anti-nucleolin antibody confirmed the nucleolar localization of mutant p53. Our observations suggest that some of the p53 in the nucleus is not tightly attached to nuclear components and can freely diffuse outside the nucleus, whereas a subpopulation of p53 in some cells can be anchored by attaching to nuclear and nucleolar components as was reported previously (Rubbi and Milner, 2000; Klibanov et al., 2001) .
Both mutant p53
Q22/S23
-and p53
H175
-expressing cells contain at least two-fold more p53 than those expressing wild-type p53 when normalized to cellular actin levels (Figure 1 and 2). We therefore tested whether the level of p53 protein can determine sequestration of the mutant p53 into the nucleolus by varying the amount of tetracycline in the culture medium of mutant p53-expressing cells (Chen et al., 1996) . Indeed, when the level of mutant p53 was lowered to that of fully expressed wild-type p53 neither p53 Q22/S23 nor p53 H175 relocalized to the nucleolus (Figure 2 ). To determine whether endogenously expressed p53 in other cell lines could relocalize to nucleoli after permeabilization, we examined HT-29 cells and T98G cells that each express high levels of mutant forms of p53. Note that the levels of endogenous mutant p53 in those cells are similar to those of p53 H175 that are expressed inducibly in H1299 cell line Chen et al., 1996; Liu and Chen, 2002; Menendez et al., 2006) . In fact, after permeabilization of both cell lines, nucleolar staining of p53 was readily detectable and predominant (Figure 1d and e). Although we were concerned that only mutant forms of p53 can associate with nucleoli when at high concentrations in cells, transfected wild-type p53 protein, which is present at markedly higher levels than endogenously expressed p53 protein, can also be found in nucleoli of permeabilized cells to roughly similar extents as the mutant forms of p53 shown in Figures 1 and 2 (data not shown). We conclude from these data that the level of p53 in permeabilized H1299 inducible cells is likely to be a critical feature in determining its intranuclear localization.
Exogenously added p53 proteins localize to nucleoli in permeabilized cells To gain further insight into the features of p53 that allow it to localize to nucleoli, we established an in vitro localization assay as reported previously for MDM2 that entailed having purified p53 present in the buffer used to permeabilize cells (Poyurovsky et al., 2003) . As seen with cellular p53, localization of exogenous p53 protein in permeabilized cells was followed by immunofluorence and DIC (Figure 3 Further, p53 nucleolar association was detected by a variety of antibodies (PAb 1801, DO-1, PAb 421, anti-GST, anti-p53 polyclonal antibody and anti-OMNI) that were used to recognize p53 or p53 fusion proteins demonstrating that epitope tags or GST fusion did not affect p53 nucleolar localization (Figure 3 and Supplementary Figure 1 ).
Several controls were performed to support the validity of these results. First, we fixed the cells before were extensively washed and then maintained in tetracycline-free medium and serum. After 48 h, cells were either directly solubilized in SDS electrophoresis sample buffer (unpermeabilized, U) or first treated with 1 ml PBS/1% Triton X-100 for 2 min before suspension in SDS electrophoresis sample buffer (permeabilized, P). Samples were then resolved by SDS-PAGE and subjected to immunoblotting with anti-p53 antibody PAb 1801. As control blots were probed for actin. (b and c) H1299 cells expressing induced wild-type p53, p53 H175 and p53 Q22/S23 as in A were either directly paraformaldehyde fixed without permeabilization (b) or permeabilized with 1 ml PBS/ 1% Triton X-100 for 2 min before fixing (c). (d and e) HT-29 and T98G cells were permeabilized with PBS/1% Triton X-100 containing buffer and then fixed. Immunostaining for p53 was performed using PAb 1801 and Cy5 coupled goat anti-mouse IgG antibody. Permeabilized cells in (c-e) were also co-stained with nucleolin antibody to visualize the nucleolus. The cells were visualized by confocal laser scanning microscopy and DIC. adding the purified p53 protein. In this case, no p53 association with nuclei or nucleoli was observed (Supplementary Figure 1E) . Second, several truncated versions of p53 failed to localize to nucleoli (Figure 3) . Perhaps most relevantly, as the basic p53 C-terminus associates efficiently with nucleoli ( Figure 3 , panel 5), a highly basic deletion mutant of highmobility-group (HMG)B1, HMG Box B domain (amino acids 90-176, K96E) (Stros and Reich, 1998) , failed to localize to nucleoli even when added at higher concentration than p53 protein (Supplementary Figure  1F) . This result argues against a possible effect of nonspecific charge on translocation of p53 to the nucleolus.
Importantly, these results were not confined to H1299 cells as, when we included purified p53 protein in the permeabilization buffer to either IMR-90 cells that, when unstressed, express low levels of wildtype p53 or to p53-null Saos-2 cells, it was possible to detect p53 that was either exclusively or predominantly nucleolar (Supplementary Figure 2) . Taken together, our results indicate that both endogenously expressed and exogenously added p53 protein can translocate to and associate with the nucleolus in Triton-permeabilized cells.
The ability to demonstrate that exogenously added purified wild-type p53 localizes to the nucleolus allowed us to identify potential region(s) of p53 responsible for this property. To address this question, we included different versions of purified p53 protein in the permeabilization buffer for H1299 cells and visualized nuclei as above ( Figure 3) . A schematic diagram and silver-stained gel of all purified forms of p53 proteins used in these experiments are shown in Figure 3a and b. Although the sources and tags of the various p53 proteins differed, we believe that this does not affect the interpretation of our data as different tagged versions of purified full-length p53 proteins localized similarly to nucleoli.
Although, as mentioned above, GST-p53 was capable of associating with nucleoli ( Figure 3c H175 and p53 Q22/S23 as in (a) were placed in medium containing 20 and 0 ng/ml tetracycline as indicated for 48 h and then either directly fixed, unpermeabilized (U) or first permeabilized (P) as in Figure 1 . Immunostaining for p53 was performed using PAb 1801 and Cy5 coupled goat anti-mouse IgG antibodies. Cells were co-stained with 10 nM SYTOX green nucleic acid stain to localize the nuclei.
ATP-dependent p53 nucleolar localization O Karni-Schmidt et al panels 2 and 3, respectively). On the other hand, N-and C-terminally deleted p53, comprising the central core, linker and tetramerization domains (amino acids 97-363; core/linker/tetra), was detected both in the nucleoplasm and nucleoli ( Figure 3c , panel 4). This was consistent with our finding that the C-terminal portion of p53 (amino acids 311-393; linker/tetra/basic) localized exclusively and very efficiently to the nucleolus ( Figure 3c , panel 5). These data suggested that one or more determinant(s) present in the linker or tetramerization regions are necessary for p53 to associate with nucleoli. It was therefore surprising that HA-p53DC30 protein lacking the C-terminal basic domain (amino acids 1-362; N/core/linker/tetra) was not concentrated in nucleoli (Figure 3 , panel 6). We cannot explain the somewhat paradoxical observation that the core/linker/ tetra construct that lacks the C-terminus was capable of concentrating in nucleoli, whereas HA-p53DC30 p53 could not. Possibly there are multiple determinants of p53 nucleolar association, one within the extreme C-terminal basic region, whereas the other(s) would reside in the linker or tetramerization regions (because the core alone did not localize to nucleoli). Data supporting this likelihood are shown below. We speculate that the p53 N-terminus may be inhibitory in cis to the nucleolar localization determinant(s) within the linker or tetramerization region. Altogether, our data strongly suggest that the carboxyl terminus of p53 (amino acids 311-393) possesses sequences that are essential for its nucleolar association. The C-terminal portion of p53 can associate with nucleoli. Schematic diagram (a) and silver stained gel (b) of purified wildtype and mutant p53 proteins. (c) H1299 cells were permeabilized before fixation for 2 min. The permeabilizing buffer was supplemented with (1) 0.4 mM full-length bacterial GST-p53, (2) 1.6 mM bacterially expressed GST-p53 N-terminus (amino acids 1-82), (3) 0.8 mM bacterially expressed his-p53 core domain (amino acids 97-303), (4) 0.4 mM bacterially expressed his-p53 core, linker and tetramerization domain (amino acids 97-363), (5) 0.4 mM baculovirally derived his-p53 C-terminus (amino acids 311-393) and (6) 0.4 mM baculovirally derived C-terminally deleted p53 (HA-p53DC30; amino acids 1-362). The p53 proteins were detected with PAb 1801 (1, 2 and 6), PAb 421 (5) or OMNI antibody (3 and 4).
Fluorescein-labeled peptides reveal that two discrete regions of p53 within its carboxyl terminus can associate with nucleoli in both permeabilized and unpermeabilized cells To focus more precisely on regions that are required for p53 nucleolar localization, fluorescein (Fl)-labeled peptides were synthesized spanning the linker region (305-322), tetramerization domain (325-355) and basic region (367-393), as well as the N-terminus (1-42). This approach has the added advantage that it is possible to synthesize peptides fully phosphorylated or acetylated at residues within p53 known to be modified in vivo after stress signaling. The subcellular localization of these peptides in permeabilized cells was examined by confocal microscopy (Figure 4) . Consistent with the fact that GST-p53 N-terminus (1-82) fails to associate with nucleoli, we observed no nucleolar localization with the Fl-1-42 peptide ( Figure 4a , panel 1). In fact, nucleolar localization of the Fl-1-42 peptide was not observed even when it was added at concentrations up to 20 mM that is, five-fold greater than shown in Figure 4 (data not shown). Additionally, we did not observe nucleolar localization of the Fl-325-355 peptide, which contains the tetramerization domain as well as a putative nuclear export signal (NES) (Figure 4a , panel 4). On the other hand, C-terminally derived peptides from two discrete regions displayed very strong nucleolar localization. The Fl-305-322 peptide was detected prominently in nucleoli as well as more weakly in the nucleoplasm ( Figure 4a , panel 2). As the same peptide when fully phosphorylated on serine 315, showed essentially the same result, which indicates that the modification of this residue is not likely to impact nucleolar localization ( Figure 4a , panels 2 and 3). Additionally peptides Fl-363-393, Fl-363-393 with acetylated lysine 382 and Fl-363-393 with phosphorylated S392 were clearly associated with nucleoli and more faintly with nucleoplasm, although the relative intensity of their fluorescein signals was weaker than those seen with Fl-305-322 ( Figure 4a , panels 5-7). Interestingly, phosphorylation at serine 392 but not acetylation at lysine 382 exerted a partial inhibitory effect on nucleolar localization, which was confirmed by using Metamorph software (Dawningtown, PA, USA) to quantify the intensity of nucleolar localization of 30 representative cells (Figure 4b ). Our data thus support the likelihood that p53 contains within its C-terminus two discrete sequences that can facilitate its association with nucleoli. Small peptides have the unique advantage that they can in some cases be taken up by intact cells (Issaeva et al., 2003) . This allowed us to determine whether any of the peptides could associate with the nucleoli in cells without prior permeabilization. Indeed, when the peptides described above were added directly to cell cultures before fixation with paraformaldehyde, our results approximated what we had seen with permeabilized cells. Note that, in contrast to permeabilized cells where nucleolar peptides were detected in nearly all of the cells, only about 5% of the intact cells allowed visualization of peptides. We did not observe any difference in gross morphology in cells that differed in their ability to take up peptides. Both Fl-305-322 and Fl-367-393 peptides displayed strong nucleolar staining, whereas Fl-1-42, Fl-325-355 and Fl-367-393-392P showed no nuclear or nucleolar staining (Figure 4c) . Further, we also tested an NES mutant version of Fl-325-355 (L348A/L350A) peptide, which showed readily detectable nucleoplasmic staining, but did not associate with nucleoli, showing that not every peptide that enters the nucleus concentrates in nucleoli (Figure 4c, panel 5) . We cannot exclude that those peptides that failed to show nuclear or nucleolar localization were not taken up by cells or were degraded more rapidly before fixation. Nevertheless, the results that peptides spanning 305-322 and 367-393 associate with nucleoli provide strong support that conditions used to permeabilize cells are not providing artifactual results. They also suggest the possibility that one or more modifications within these sequences may have an impact on such localization.
Nucleolar localization of p53 after proteasome inhibition in unpermeabilized cells requires the p53 carboxyl terminus It was important to show that the C-terminus of p53 is required for nucleolar localization in unpermeabilized cells. Previous reports showed that p53 localizes to nucleoli after treatment of cells with the proteasome inhibitor MG132 (Klibanov et al., 2001; Latonen et al., 2003) . Here, we have confirmed and extended these findings by identifying regions and sites that affect p53 localization under these conditions. In H1299 p53-null cells transfected with wild-type p53, MG132 treatment led to p53 nucleolar localization in approximately 20% of the cells (Figure 5b and c, panel 1 ). To gain information about which regions of p53 were involved, we used a number of constructs in which either the C-terminus was deleted (p53DC30) or lysine residues within the C-terminal 30 amino acids affecting nuclear localization signal (NLS) sequences NLS II and NLS III were mutated to either arginine (p53 6KR ) or glutamine (p53 6KQ ), as well as constructs in which lysines in both the linker region and the carboxyl terminus were mutated to either arginine (p53 8KR ) or glutamine (p53 8KQ ) (see Figure 5a) . We also generated a construct p53 8KQ-SVNLS in which the SV40 NLS was fused to the carboxyl terminus of this mutant (Figure 5a ). In transfected H1299 cells p53 6KR , p53
6KQ and p53
8KR
localized to the nucleolus after MG132 treatment to roughly the same extent as wild-type p53 (Figure 5b ). By contrast, neither transfected p53DC30 nor p53 8KQ were detected in nucleoli (Figure 5b ). p53 8KQ was primarily cytoplasmic with weak nucleoplasmic staining (Figure 5c, panel 3) , which could explain its failure to associate with nucleoli. When we transfected p53 to the cells, however, p53 was detected exclusively in the nucleoplasm demonstrating the effectiveness of the SV40 NLS. It was therefore striking that the accumulation of p53 8KQ-SVNLS to the nucleolus after proteasome inhibition was markedly decreased (Figure 5b , panel 4) . This supports the likelihood that p53 has bona fide nucleolar localization signal sequences rather than its nucleolar association being an indirect result of its being present in the nucleus.
We also compared Flag-tagged versions of wildtype p53, a neutral S392 substitution mutant p53 S392A and a phosphorylation mimicking mutant p53 S392D . Importantly, after treatment of cells with MG132, Taken together, these data (1) validate our experiments with p53 proteins' and peptides' localization to nucleoli in permeabilized cells; (2) show that the carboxyl terminus of p53 plays an important role in redirecting p53 to the nucleolus after proteasome inhibition and (3) provide impetus for our 6KR and p53 8KR refer to substitution mutants in which the indicated lysine residues were changed to arginine; p53 6KQ or p53 8KQ refer to mutants in which these lysines were changed to glutamine. p53 refer to the substitution mutant 8KQ in which the SV-40 NLS was added to its carboxyl terminus. p53 S392A/S392D refer to mutants in which the amino acid serine was substituted to either alanine or aspartate, respectively. In each case H1299 p53-null cells were transfected with different versions of p53 (1 mg of plasmid in each case) and treated with 10 mM MG132 for 8 h as described in Materials and methods. Cells were directly fixed and analysed as detailed in Figure 1 ATP-dependent p53 nucleolar localization O Karni-Schmidt et al subsequent experiments described below examining the effect of genotoxic stress on p53 nucleolar localization.
ATP hydrolysis is required for p53 localization to the nucleolus
We considered the possibility that p53 nucleolar localization might be energy-dependent. To determine whether there is a requirement for cellular adenosine triphosphate (ATP) for p53 nucleolar localization before permeabilization, cells were pre-treated with a combination of sodium azide (which inhibits cytochrome oxidase) and 2-deoxyglucose (which inhibits glycolysis) to substantially reduce the levels of ATP in the cells (Figure 6 ). When cells were first treated with 2-deoxyglucose and sodium azide (Az/DOG), almost no p53 could be detected in the nucleolus although it was readily detected in the nucleoplasm. Importantly, the effect of prior Az/DOG treatment was reversible, as adding ATP to the permeabilization buffer along with the purified p53 protein resulted in a significant (approximately six-fold) increase in the percent of cells in which p53 protein localized to the nucleolus (Figure 6a , panel 3 and see graph at right). Weak nucleoplasmic staining was also always observed in this case. ATP hydrolysis is required for nucleolar localization of p53. (a) H1299 p53 null cells were either untreated or pre-treated with 5 mM sodium azide and 1 mM 2-deoxyglucose for 45 min (upper left panels) before permeabilization with PBS/1% Triton X-100 containing purified bacterial wild-type his-p53 protein with or without addition of 4 mM ATP. Cells were then fixed and stained as in Figure 3 . Bar graph on right shows percentage of cells with nucleolar localization of his-p53 protein after the indicated conditions. The graph represents two independent experiments where at least 200 cells were counted for each slide. (b) Purified bacterial wild-type hisp53 protein was either present in the PBS/1% Triton X-100 permeabilization buffer (panels 1), or added 3 min after the cells were incubated with PBS/1% Triton X-100 supplemented with 4 mM ATP (panels 3), 4 mM ADP (panels 4) or 4 mM ATPgS (panels 5). Cells were then fixed and stained as in Figure 2 . The graph at right shows the percentage of cells with nucleolar localization of exogenous purified p53 protein after the different treatments. The graph was prepared as in (a). Immunostaining for p53 was performed as described in Figure 1 .
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To test whether ATP hydrolysis is a requirement for nucleolar localization, cells were pre-permeabilized (P) with PBS/1% Triton X-100 for 3 min before addition of p53 protein (0.4 mM) in the same buffer for an additional 3 min (Figure 6b ). Without added ATP p53 was primarily detected in the nucleoplasm, whereas, as before, when cells were permeabilized directly with buffer containing p53 protein, nucleolar staining was evident (Figure 6b, panels 1 and 2) . Similar experiments were performed in which the cells were incubated with the pre-permeabilization buffer containing 4 mM adenosine diphosphate (ADP) and ATPgS for 3 min followed by addition of buffer containing purified his-p53 protein. Nucleolar and nucleoplasmic staining of p53 was detected when the cells were incubated with ATP before addition of the purified p53 protein. However, no nucleolar staining of p53 was observed in cells that were pre-permeabliized with ADP or ATPgS (Figure 6b , panels 4 and 5). This result indicates that ATP hydrolysis facilitates movement of p53 to the nucleolus. It should be mentioned that localization of small peptides to nucleoli occurred in an ATP-independent manner. Although we do not as yet understand the basis for these differences, our data nevertheless indicate that nucleolar localization of full-length p53 can be an actively regulated energy-dependent process.
Genotoxic stress decreases p53 association with the nucleolus It was interesting to determine whether forms of cellular stress that impact p53 could affect its association with nucleoli. We examined both exogenous and endogenous p53 nucleolar localization in cells treated with daunorubicin, a topoisomerase II inhibitor and an intercalating agent, ultraviolet (UV) irradiation or actinomycin D, an inhibitor of RNA transcription (Figure 7) . At 16 h after treatment with these agents, cells were permeabilized with or without exogenous p53 protein as indicated and then fixed and treated as before. Importantly, each of these treatments had a dramatic inhibitory effect on the ability of both exogenous and endogenous p53 to associate with nucleoli such that p53 was restricted to the nucleoplasm. Subnuclear localization of p53 and another nucleolar protein, nucleophosmin, were examined by immunofluorescence using their respective antibodies. Note that after actinomycin D treatment nucleophosmin localized mainly to the nucleoplasm indicating partial disruption of nucleolar structure as described previously (Zatsepina et al., 1989; Chan et al., 1996; Haaf and Ward, 1996) .
We cannot rule out that these treatments have an effect on nucleolar integrity, which prevents p53 from associating with this organelle. In fact, we have extended previous observations implicating a role for RNA in p53 nucleolar association by showing that RNase A treatment prevents both endogenous and recombinant p53 from accumulating in nucleoli of permeabilized cells (Supplementary Figure 3) . Nevertheless, p53 is phosphorylated at S392 after some forms of DNA damage (Appella and Anderson, 2001 ), and we found that both a peptide phosphorylated at this site and a phosphomimetic mutant p53 S392D were somewhat impaired in nucleolar localization suggesting that modification of the p53 protein itself is a determinant of p53 trafficking within the nucleus.
Discussion
We show herein that both endogenously expressed mutant p53 protein and exogenously added wild-type and mutant p53 can localize to the nucleolus in a concentration-and ATP-dependent manner. We have also identified two discrete regions within the carboxyl terminus of p53 that are essential for nucleolar localization: amino acids 305-322 (NLS I) and the C-terminal basic domain (amino acids 363-393). Furthermore, we found that the treatment of the cells with DNAdamaging agents decreases the association of p53 with the nucleolus.
Use of fluorescein labeled peptides provided us with important information. First, it allowed us to definitively identify two discrete regions on p53 that can associate with nucleoli. Second, the fact that these same peptides when taken up by intact cells could also be found associated predominantly with nucleoli lends considerable support for our results obtained by prepermeabilization of cells. Third, our results with modified peptides suggest that phosphorylation of p53 at select sites might negatively regulate p53 association with nucleoli, consistent with the observation that DNA damage prevents this association. This was nicely supported by the observation that the substitution mutation in p53 S392D showed a decrease in p53 nucleolar accumulation after proteasome inhibitor treatment.
Although our results confirm and extend other studies demonstrating that p53 can associate with nucleoli, they pose a number of questions. Figure 7 Nucleolar association of p53 is reduced after genotoxic stress. The subnuclear localization of p53 in H1299 cells permeabilized with exogenously added purified bacterially expressed wild-type his-p53 protein (as in Figure 2 ) or permeabilized H1299 expressing inducible p53 H175 and T98G cells expressing endogenous mutant p53 (as in Figure 1 ) was determined. Cells were examined after treatment with 0.22 mM daunorubicin, 0.4 mM actinomycin D and UV irradiation of 25 J/M 2 for 16 h. Graphic representation shows the percentage of different cells with nucleolar p53 after different treatments. The graph was prepared as in Figure 6a .
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What is the mechanism by which p53 associates with nucleoli? It was reported that macromolecular transport inside the nucleolus is controlled by a combination of passive diffusion and ATP-dependent processes (Carmo-Fonseca et al., 2002) . In line with this, our results show that nucleolar localization of p53 is facilitated by active ATP hydrolysis. Identification of the energy-requiring machinery that facilitates p53 association would provide useful insight into the mechanism of this process.
What are the nucleolar localization signals on p53? Nucleolar localization signal sequences have been identified in several proteins notably ribosomal proteins, and nucleolar components such as nucleolin and nucleophosmin. With respect to p53, the one common functional feature of the two nucleolar-associating regions of p53 is their possession of nuclear-localization sequences. It can be speculated that as nucleoli do not possess defined membrane barriers and thus may not have a system akin to nuclear transport machinery (such as importins, nuclear pore complex and exportins), proteins that localize to nucleoli might do so as a result of specific interactions with binding sites within nucleolar components. Identification of the nucleolar components that facilitate p53 nucleolar localization would greatly illuminate this question.
Results with p53 C-terminal lysine substitution mutants should also help clarify the process. Those that allowed nucleolar localization (p53 6KR , p53 6KQ or p53 8KR ) had positively charged residues in the linker region containing NLS I. Nevertheless, the fact that p53DC30 that has this region failed to display such localization indicates that the situation is more complex. A version of p53 with its own nucleolar/NLS sequences mutated but with an unrelated NLS (SV40) can enter the nucleus but is severely impaired in nucleolar association. This argues that the association of p53 with nucleoli is meaningful, although, because the motifs that are crucial for nucleolar localization overlap the p53 NLSs, it will be challenging to perform a more refined analysis of the putative amino acids participating in localizing p53 to the nucleolus. However, in agreement with our experiments using exogenously added purified proteins and peptides, we conclude that the carboxyl terminus of p53 plays an important role in redirecting p53 to the nucleolus after proteasome inhibition.
Why sequester p53 in the nucleolus? A number of different scenarios can be considered. Studies have indicated that nucleolar sequesteration can be a mechanism for inhibiting protein function (Visintin and Amon, 2000; Zimber et al., 2004) . Perhaps inappropriate overexpression of p53 results in its relocalization to nucleoli where, when required, it may more rapidly reenter the nucleoplasm. This is consistent with our observation that only high levels of endogenous p53 permit its association with nucleoli after detergent permeabilization. In MG132-treated cells, p53 and MDM2 proteins co-localize in the nucleolus following accumulation of high levels of p53 protein (Klibanov et al., 2001) . In addition, both p53 and MDM2 have been reported to be degraded in the nucleus under certain treatments (Xirodimas et al., 2001; Shirangi et al., 2002) . Another possibility is that the nucleolus may serve as a transit station for p53 nuclear export. The model for this is the HIV-1 Rev protein (Dundr et al., 1995; Zolotukhin and Felber, 1999) . Importantly, both p53 and Rev utilize CRM1 for their export (Thomas and Kutay, 2003) . Finally, the nucleolus is the site of ribosomal RNA synthesis, and transcription by RNA polymerase I occurs at a high rate in this region. That p53 can repress transcription by RNA polymerase I in vitro and in vivo may therefore be relevant to our findings (Budde and Grummt, 1999) . Perhaps a subset of p53 is always found in nucleoli as speculated previously (Rubbi and Milner, 2000) and what we have discovered is the basis of a mechanism for getting it there. The detailed mechanism of how p53 is targeted to nucleoli and the physiological relevance of this process remains to be elucidated.
What keeps p53 away from the nucleolus?
We have identified in vitro conditions where the p53 C-terminus and discrete portions of this region can localize rather efficiently in vitro to nucleoli. Yet nucleolar localization of endogenously expressed fulllength p53 is only rarely documented (Young et al., 2002) and, instead, this phenomenon is found under only specialized circumstances, such as pre-permeabilization or treatment of cells with a proteasome inhibitor. It is therefore likely that there are features of the full-length protein that preclude its efficient association with this subnuclear structure. Our result that p53 residues 97-363 (core/linker/tet) can concentrate within nucleoli, whereas p53 residues 1-363 (N/core/ linker/tet) cannot (Figure 3) suggests that the Nterminus can somehow prevent the functioning of the p53 nucleolar localization sequence within its linker region. As the functioning of the other putative NoLS at the extreme C-terminus was partially inhibited by phosphorylation at S392 (Figure 4 ) and the association of the transfected mutant p53 S392D with nucleoli was substantially lower after MG132 treatment perhaps this and other modification(s) may also contribute to exclude p53 from this structure. This cannot be the sole explanation, however, as we found that bacterially expressed p53 could localize to nuclei in unstressed cells but not in cells subjected to DNA damage, the recombinant p53 protein is unlikely to become efficiently modified in the permeabilized cells. We cannot exclude that one or more components of the machinery that allows p53 to associate with nucleoli may be regulated by DNA damage.
The establishment of an in vitro system for studying p53 nucleolar localization may eventually provide answers to these and other questions
Materials and methods
Cell culture H1299 cells expressing tetracycline-regulated wild-type p53 (p53-14), the transactivation domain mutant, p53
Q22/S23 and the specific DNA-binding domain mutant, p53 H175 were generated as described previously (Resnitzky et al., 1994; Chen et al., 1996) . Cells were grown and maintained in Rosewell's Park Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum (FBS), puromycin (2 mg/ml; Sigma, St Louis, MO, USA), G418 (300 mg/ml; Invitrogen, Carlsbad, CA, USA) and tetracycline (4.5 mg/ml). To induce p53, medium was removed from cultures, which were washed with PBS before plating in the above medium lacking tetracycline for 48 h. HT-29 cells were grown in McCoy medium supplemented with 10% FBS, whereas T98G cells and IMR-90 were grown in minimal essential medium with 2 mM Lglutamine supplemented with 10% FBS. Saos-2 cells were maintained in Dulbecco's modified Eagle's, and H1299 cells were maintained in RPMI medium. All above medium were supplemented with 10% FBS.
Immunoblot analysis p53 in H1299 cells was induced for 48 h at full or partial levels by varying the amount of tetracycline in the medium. Cells were washed twice with PBS and then collected by scraping in cold extraction buffer (10 mM Tris (pH 7.5), 1 mM ethylenediaminetetraacetate, 400 mM NaCl, 10% glycerol, 0.5% NP40, 5 mM NaF, 1 mM dithiothreitol and 0.1 mM phenylmethylsulfonyl fluoride (PMSF)) followed by centrifugation at 13 000 r.p.m. for 10 min. The supernatants were resuspended in 3 Â protein sample buffer and boiled for 10 min. Proteins were separated by SDS-PAGE using 10% polyacrylamide gels and transferred to nitrocellulose for 3 h. The monoclonal antibody PAb 1801 was used to detect p53 and an antiactin antibody (Sigma) was used as a loading control.
Immunofluorescence, cell permeabilization assays Depending on the experiment, several different antibodies were used in these experiments. Monoclonal anti-p53 antibodies included PAb 1801, PAb DO1 and PAb 421. Additionally anti-GST, anti-p53 polyclonal antibody, anti-OMNI and antinucleophosmin polyclonal antibodies were used and purchased from Santa-Cruz Biotechnology Inc. (Santa Cruz, CA, USA). The antinucleolin antibody was described previously (Ghisolfi-Nieto et al., 1996) . To detect total p53 in cells without prior permeabilization (i.e., by direct fixation), cultures were grown on coverslips in 35 mm plates (with or without 4 mg/ml tetracycline). Twenty-four hours later, where applicable, medium was removed from cultures and replaced with fresh tetracycline-free medium. Forty-eight hours after plating the cells were washed twice with PBS and then fixed for 15 min with 4% paraformaldehyde (Sigma) followed by three washes in PBS. Cells were then treated with PBS/0.5% Triton X-100 for 1.5 min followed by blocking with 0.5% bovine serum albumin (Sigma) for 30 min at room temperature before preparation for immunofluorescence.
To detect p53 in pre-permeablized cells, 60 mm culture dishes were incubated with 0.2 ml PBS/1% Triton X-100 supplemented with protease inhibitors (100 mM sodium orthovanadate, 50 mM PMSF and 10 mg/ml chymostatin, leupeptin, antipain and pepstatin) for approximately 2 min, that is, until only nuclei without cytoplasm were visible in at least 80% of the cells. Nuclei were then fixed immediately with 4% paraformaldehyde for 15 min followed by preparation for visualization by immunofluorescence as described above.
For experiments in which cells were either directly fixed or pre-permeabilized with PBS/1% Triton X-100, immunofluorescence was performed by adding 50 ml of diluted primary antibody solution to coverslips. After 1 h of incubation at room temperature, coverslips were washed and then incubated for 1 h with 50 ml of diluted (1:100) secondary Cy5 goat antimouse IgG antibody (Jackson Immunoresearch), Alexa fluor 488 goat anti-rabbit or Alexa fluor 594 donkey anti-goat antibodies (Molecular Probes, Eugene, OR, USA). Coverslips were washed three times with PBS after each of the above steps, mounted on a microscope slide with 10 ml of cold 50% glycerol, and images were analysed by confocal laser scanning microscopy (Olympus model 1X70) using Fluoview software (Canter Valley, PA, USA). DIC imaging was used in parallel to directly visualize nuclei and nucleoli. In general, localization of p53 proteins and peptides were determined by visually screening fields of at least 200 cells and choosing representative images.
DNA staining was performed using 10 nM SYTOX Green nucleic acid dye (Molecular Probes) for 10 min. To inhibit proteasome function, cells were incubated with MG132 (10 mM) for 8 h. For ATP-depletion experiments, cells were washed twice with PBS and then were incubated for 45 min at room temprature with 5 mM sodium azide (NaN 3 ) and 1 mM 2-deoxyglucose. To induce genotoxic stress, cells were treated with 0.22 mM daunorubicin (Sigma), 0.4 mM actinomycin D (Calbiochem, San Diego, CA, USA) or 25 J/m 2 UV light in a UV Crosslinker (Fisher Scientific, Pittsburgh, PA, USA) 16 h before detection of exogenously added or endogenously expressed p53. For RNase treatment, 200 U/ml RNase A (Sigma) as added to the permeabilization buffer.
In vitro localization assay H1299 cells were plated on cover slips in 35-mm dishes and grown to 80% confluence. The cells were washed twice with PBS and permeabilized with 0.2 ml PBS/1% Triton X-100 supplemented with the purified protein (0.4 mM) or fluoresceinlabeled peptides (4-16 mM) for 2 min followed by fixation with 4% paraformaldehyde (Poyurovsky et al., 2003) . Immunofluorescence was performed as described above.
Expression and purification of recombinant p53 proteins Baculoviruses that express mutant p53 H175 , p53 lacking amino acids 363-393 (HA-p53DC30), his-p53C-terminus domain of p53 (amino acids 311-393) and wild-type HA-p53 were previously described (Jayaraman and Prives, 1995; Jayaraman et al., 1997) . Infection and purification of p53 proteins from insect cells was performed as before (Jayaraman et al., 1997) .
Transfection and plasmids
Transfections were performed using Lipofectamine 2000 reagent (Invitrogen), according to the manufacturer's protocols. Expression vectors derived from pcDNA3 were pc53 expressing full-length p53 cDNA, pc53DC30 expressing p53 lacking the last 30 amino acids, Flag-tagged wild-type p53 and Flag-tagged substitution mutant p53 in which serine 392 was substituted with either alanine or aspartate, respectively. Substitution mutants p53 6KR and p53 6KQ (amino acids 370, 372, 373, 380, 381 and 386 substituted with arginine and glutamine, respectively), and p53 8KR and p53 8KQ (amino acids 305, 320, 370, 372, 373, 380, 381 and 386 substituted with arginine and glutamine, respectively) were made by using the QuickChange II SiteDirected Mutagenesis Kit (Stratagene, La Jolla, CA, USA) on pTRE2-hyg (Invitrogen) with p53 cDNA ligated between Nhe1 and EcoRV sites. In order to make the p53 8KQ-SVNLS construct, the SV-40 NLS sequence (PKKKRK) was added to the carboxyl terminus of the p53 8KQ using the same vector as described above. All substitution mutants were confirmed by sequencing.
Peptide synthesis
Peptides used in these studies were synthesized on a Pioneer peptide synthesizer (Applied Biosystems, Foster City, CA, USA) using standard Fmoc chemistry (FernandezFernandez et al., 2005) . Double couplings were used when needed. The peptides were labeled with fluorescein at the N-terminus while still on the resin on the Pioneer peptide synthesizer using a four-fold excess of fluorescein-OSu (Molecular Probes) and a four-fold excess of hydroxybenzotriazole. This procedure ensures that the peptide is labeled specifically at its N-terminus at 100% yield. All other amino acids were purchased from NOVAbiochem, La Jolla, CA, USA. The peptides were purified on a Waters HPLC using a reverse-phase C8 preparative column (Vydac, Hesperia, CA, USA).
